Defining uremic arterial functional abnormalities in patients recently started on haemodialysis: combined in vivo and ex vivo assessment.

Endothelial dysfunction is a key initiating event in vascular disease in chronic kidney disease (CKD) patients and haemodialysis (HD) patients exhibit significant vascular abnormalities. To understand this further, we examined how ex vivo intrinsic function in isolated arteries correlates with in vi...

Full description

Bibliographic Details
Main Authors: Adil M Abushufa, Mohamed T Eldehni, Aghogho Odudu, Philip D Evans, Saoirse E O'Sullivan, Chris W McIntyre
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4278673?pdf=render
id doaj-734ab9e15df1468f9f4dee518ac7c9e2
record_format Article
spelling doaj-734ab9e15df1468f9f4dee518ac7c9e22020-11-24T21:50:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01912e11346210.1371/journal.pone.0113462Defining uremic arterial functional abnormalities in patients recently started on haemodialysis: combined in vivo and ex vivo assessment.Adil M AbushufaMohamed T EldehniAghogho OduduPhilip D EvansSaoirse E O'SullivanChris W McIntyreEndothelial dysfunction is a key initiating event in vascular disease in chronic kidney disease (CKD) patients and haemodialysis (HD) patients exhibit significant vascular abnormalities. To understand this further, we examined how ex vivo intrinsic function in isolated arteries correlates with in vivo assessments of cardiovascular status in HD patients. Abdominal fat biopsies were obtained from 11 HD patients and 26 non-uremic controls. Subcutaneous arteries were dissected and mounted on a wire myograph, and cumulative concentration-response curves to noradrenalin, endothelin-1, a thromboxane A2 agonist (U46619), angiotensin II, vasopressin, bradykinin (BK), acetylcholine (ACh) and sodium nitroprusside (SNP) were constructed. Pulse wave velocity and blood pressure were measured in HD patients. Enhanced (P<0.05-0.0001) maximal contractile responses (Rmax) to all spasmogens (particularly vasopressin) were observed in arteries from HD patients compared to controls, and this effect was more pronounced in arteries with an internal diameter>600 µm. The potency (pEC50) of U46619 (P<0.01) and vasopressin (P<0.001) was also increased in arteries>600 µm of HD patients. The maximal relaxant response to the endothelium-dependent dilators ACh and BK were lower in HD patients (P<0.01-P<0.0001) (worse for ACh than BK); however the endothelium-independent dilator SNP was similar in both groups. PWV was significantly correlated with the vasoconstrictor response to vasopressin (P = 0.042) in HD patients. HD patients are primed for hypertension and end organ demand ischaemia by a highly sensitised pressor response. The failure of arterial relaxation is mediated by endothelial dysfunction. Intrinsic vascular abnormalities may be important in sensitising HD patients to recurrent cumulative ischaemic end organ injury.http://europepmc.org/articles/PMC4278673?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Adil M Abushufa
Mohamed T Eldehni
Aghogho Odudu
Philip D Evans
Saoirse E O'Sullivan
Chris W McIntyre
spellingShingle Adil M Abushufa
Mohamed T Eldehni
Aghogho Odudu
Philip D Evans
Saoirse E O'Sullivan
Chris W McIntyre
Defining uremic arterial functional abnormalities in patients recently started on haemodialysis: combined in vivo and ex vivo assessment.
PLoS ONE
author_facet Adil M Abushufa
Mohamed T Eldehni
Aghogho Odudu
Philip D Evans
Saoirse E O'Sullivan
Chris W McIntyre
author_sort Adil M Abushufa
title Defining uremic arterial functional abnormalities in patients recently started on haemodialysis: combined in vivo and ex vivo assessment.
title_short Defining uremic arterial functional abnormalities in patients recently started on haemodialysis: combined in vivo and ex vivo assessment.
title_full Defining uremic arterial functional abnormalities in patients recently started on haemodialysis: combined in vivo and ex vivo assessment.
title_fullStr Defining uremic arterial functional abnormalities in patients recently started on haemodialysis: combined in vivo and ex vivo assessment.
title_full_unstemmed Defining uremic arterial functional abnormalities in patients recently started on haemodialysis: combined in vivo and ex vivo assessment.
title_sort defining uremic arterial functional abnormalities in patients recently started on haemodialysis: combined in vivo and ex vivo assessment.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description Endothelial dysfunction is a key initiating event in vascular disease in chronic kidney disease (CKD) patients and haemodialysis (HD) patients exhibit significant vascular abnormalities. To understand this further, we examined how ex vivo intrinsic function in isolated arteries correlates with in vivo assessments of cardiovascular status in HD patients. Abdominal fat biopsies were obtained from 11 HD patients and 26 non-uremic controls. Subcutaneous arteries were dissected and mounted on a wire myograph, and cumulative concentration-response curves to noradrenalin, endothelin-1, a thromboxane A2 agonist (U46619), angiotensin II, vasopressin, bradykinin (BK), acetylcholine (ACh) and sodium nitroprusside (SNP) were constructed. Pulse wave velocity and blood pressure were measured in HD patients. Enhanced (P<0.05-0.0001) maximal contractile responses (Rmax) to all spasmogens (particularly vasopressin) were observed in arteries from HD patients compared to controls, and this effect was more pronounced in arteries with an internal diameter>600 µm. The potency (pEC50) of U46619 (P<0.01) and vasopressin (P<0.001) was also increased in arteries>600 µm of HD patients. The maximal relaxant response to the endothelium-dependent dilators ACh and BK were lower in HD patients (P<0.01-P<0.0001) (worse for ACh than BK); however the endothelium-independent dilator SNP was similar in both groups. PWV was significantly correlated with the vasoconstrictor response to vasopressin (P = 0.042) in HD patients. HD patients are primed for hypertension and end organ demand ischaemia by a highly sensitised pressor response. The failure of arterial relaxation is mediated by endothelial dysfunction. Intrinsic vascular abnormalities may be important in sensitising HD patients to recurrent cumulative ischaemic end organ injury.
url http://europepmc.org/articles/PMC4278673?pdf=render
work_keys_str_mv AT adilmabushufa defininguremicarterialfunctionalabnormalitiesinpatientsrecentlystartedonhaemodialysiscombinedinvivoandexvivoassessment
AT mohamedteldehni defininguremicarterialfunctionalabnormalitiesinpatientsrecentlystartedonhaemodialysiscombinedinvivoandexvivoassessment
AT aghoghoodudu defininguremicarterialfunctionalabnormalitiesinpatientsrecentlystartedonhaemodialysiscombinedinvivoandexvivoassessment
AT philipdevans defininguremicarterialfunctionalabnormalitiesinpatientsrecentlystartedonhaemodialysiscombinedinvivoandexvivoassessment
AT saoirseeosullivan defininguremicarterialfunctionalabnormalitiesinpatientsrecentlystartedonhaemodialysiscombinedinvivoandexvivoassessment
AT chriswmcintyre defininguremicarterialfunctionalabnormalitiesinpatientsrecentlystartedonhaemodialysiscombinedinvivoandexvivoassessment
_version_ 1725882534484508672